Alpha-MSH-derived tripeptide

KPV

Lys-Pro-Val

Preclinical / not FDA-approved

A three-amino-acid fragment related to alpha-melanocyte-stimulating hormone, studied mainly in cell and animal models of inflammation.

FULL RESEARCH GRAPHIC

KPV research overview

A dedicated overview of the alpha-MSH-derived tripeptide, preclinical inflammatory research, and the 10 mg vial.

Cybertide KPV 10 mg research infographic covering inflammatory signaling and barrier models

Tap the graphic to open the full-resolution version.

CYBERTIDE // VISUAL PROFILEKPV
PROFILE18
IDENTITYLys-Pro-ValAlpha-MSH-derived tripeptide

RESEARCH SIGNAL MAP

04 ACTIVE FIELDS
NODE 01Inflammatory signaling
NODE 02Barrier models
NODE 03Innate immunity
NODE 04Peptide transport

EVIDENCE READOUT

Preclinical / not FDA-approved

Mechanistic and animal findings are not enough to establish a safe human dose, an effective route, or long-term outcomes.

BOUNDARY CHECK

CONTEXT REQUIRED

KPV has no FDA-approved human indication, standardized injectable product, or recognized reconstitution protocol.

RESEARCH CONTEXT • PRIMARY SOURCE LINKED • QR READYSOURCE ↗

SUBMITTED LAB DOCUMENTS

Test results

Reports may describe other strengths or blends. Match the labeled amount, composition, and exact lot to your vial. A report for another strength does not verify your vial. Each record identifies whether an exact lot was supplied.

VIAL REFERENCE

3 mL mixing math & dosing context

Every number is labeled by evidence level. The 3 mL reference calculates concentration and U-100 volume; it does not prove solvent compatibility, sterility, stability, or suitability for injection.

VIAL STRENGTH

10 mg vial

AFTER 3.0 mL3.33 mg/mL0.03 mg per U-100 unit
AMOUNTVOLUMEU-100
100 mcg0.03 mL3 units
250 mcg0.07 mL7.5 units
500 mcg0.15 mL15 units
LIVE CALCULATOR

Change the liquid. See the amount.

U-100
CONCENTRATION3.333 mg/mL
DRAW VOLUME0.1 mL
AMOUNT IN THAT DRAW0.333 mg333.3 mcg

Calculation only: vial amount ÷ liquid volume × draw volume. It does not determine what dose to use or confirm product compatibility.

01 / MIXING REFERENCE

3.0 mL BAC-water workflow

  1. First confirm that bacteriostatic water and a 3.0 mL final volume are compatible with the exact product and vial capacity.
  2. Clean both vial stoppers with alcohol and allow them to dry.
  3. Add the 3.0 mL slowly down the inside wall instead of directing pressure onto the powder.
  4. Gently roll or swirl until dissolved; do not shake.
  5. Use product-specific refrigeration and discard guidance. If none exists, do not invent a beyond-use date.
NO ESTABLISHED HUMAN GUIDELINE

No established human dose

KPV research is predominantly cellular and preclinical. There is no FDA-approved indication, standardized injectable product, or recognized human reconstitution and dosing protocol.

PubMed — KPV research index ↗

U-100 means 100 units = 1.0 mL. Any table result above 100 units exceeds one standard 1 mL U-100 syringe.

PRIMARY CONTEXTPubMed — KPV research index
Open source ↗
NEXT INFOGRAPHIC5-Amino-1MQ →